サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1409674

疼痛管理薬の世界市場レポート 2024年

Pain Management Drugs Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
疼痛管理薬の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

疼痛管理薬市場規模は近年力強く成長しています。2023年の767億6,000万米ドルから2024年には810億8,000万米ドルに、CAGR5.6％で拡大します。過去に見られた成長は、慢性疼痛症例の増加、がん症例の増加、外科的処置の増加、疼痛評価方法の改善、政府の取り組みなどの要因によるものです。

疼痛管理薬市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR5.6％で1,009億4,000万米ドルに成長します。予測期間中に予想される成長は、非オピオイド代替薬の採用、標的療法の開発、精密医療アプローチ、心理学的介入の実施、副作用を最小限に抑えるための集中的な取り組みに起因すると考えられます。予測期間中に予想される主な動向には、価値に基づくケアモデルの採用、アクセス拡大プログラム、併用療法の探求、革新的な製剤の開発、バイオシミラー鎮痛薬の出現などが含まれます。

手術件数の増加が予想されることから、疼痛管理薬市場の成長が見込まれます。外科的処置は、治療目的や身体機能の強化のために体内組織を切開または貫通する医療介入を伴う。疼痛管理薬は、術後の痛みを抑制・緩和し、患者の快適性と回復の向上に貢献するため、手術において極めて重要です。2021年、外科手術は2020年比で54％増と大幅な伸びを示し、非外科手術も44％増となったと美容学会が報告しています。このような手術率の急増は、疼痛管理薬市場を推進する大きな要因となっています。

疼痛管理薬市場の成長は、老人人口の増加によってさらに押し上げられると予想されます。老年人口は65歳以上で構成され、関節炎、がん、神経障害など、後期高齢者に多く見られる症状を緩和するために疼痛管理薬を必要とすることが多いです。2022年10月の世界保健機関（WHO）の報告によると、2030年までに世界の6人に1人が60歳以上になり、2050年までに60歳以上の人口は21億人に倍増すると予測されています。さらに、2020年から2050年の間に、80歳以上の高齢者は4億2600万人増加します。こうした高齢化社会への人口動態の変化が、疼痛管理薬市場の成長の原動力となっています。

2023年の疼痛管理薬市場では北米が最大地域でした。アジア太平洋は予測期間中、疼痛管理薬市場レポートにおいて最も急成長する地域となる見込みです。疼痛管理薬市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 疼痛管理薬市場の特徴

第3章 疼痛管理薬市場の動向と戦略

第4章 疼痛管理薬市場- マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の疼痛管理薬市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 疼痛管理薬市場セグメンテーション

  • 世界の疼痛管理薬市場、薬剤クラス別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 非ステロイド性抗炎症薬（NSAID）
  • 麻酔薬
  • 抗けいれん薬
  • 抗片頭痛薬
  • 抗うつ薬
  • オピオイド
  • 非麻薬性鎮痛薬
  • 世界の疼痛管理薬市場、適応症別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 関節炎の痛み
  • 神経因性疼痛
  • がんの痛み
  • 慢性腰痛
  • 術後の痛み
  • 片頭痛
  • 線維筋痛症
  • 肉離れ・捻挫
  • 骨折
  • その他の適応症
  • 世界の疼痛管理薬市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第7章 疼痛管理薬市場の地域および国分析

  • 世界の疼痛管理薬市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の疼痛管理薬市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋の疼痛管理薬市場

第9章 中国の疼痛管理薬市場

第10章 インドの疼痛管理薬市場

第11章 日本の疼痛管理薬市場

第12章 オーストラリアの疼痛管理薬市場

第13章 インドネシアの疼痛管理薬市場

第14章 韓国の疼痛管理薬市場

第15章 西欧の疼痛管理薬市場

第16章 英国の疼痛管理薬市場

第17章 ドイツの疼痛管理薬市場

第18章 フランスの疼痛管理薬市場

第19章 イタリアの疼痛管理薬市場

第20章 スペインの疼痛管理薬市場

第21章 東欧の疼痛管理薬市場

第22章 ロシアの疼痛管理薬市場

第23章 北米の疼痛管理薬市場

第24章 米国の疼痛管理薬市場

第25章 カナダの疼痛管理薬市場

第26章 南米疼痛管理薬市場

第27章 ブラジルの疼痛管理薬市場

第28章 中東の疼痛管理薬市場

第29章 アフリカの疼痛管理薬市場

第30章 疼痛管理薬市場の競合情勢と企業プロファイル

  • 疼痛管理薬市場の競合情勢
  • 疼痛管理薬市場の企業プロファイル
    • Novartis AG
    • Eli Lilly And Company
    • Abbott Laboratories
    • Endo International plc
    • Purdue Pharma LP

第31章 世界の疼痛管理薬市場の競合ベンチマーキング

第32章 世界の疼痛管理薬市場の競争ダッシュボード

第33章 疼痛管理薬市場における主要な合併と買収

第34章 疼痛管理薬市場の将来展望と可能性分析

第35章 付録

目次
Product Code: r11212

“Pain Management Drugs Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pain management drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pain management drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The pain management drugs market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Drug Class: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Anesthetics; Anticonvulsants; Anti-migraine Agents; Antidepressants; Opioids; Nonnarcotic Analgesics
  • 2) By Indication: Arthritic Pain; Neuropathic Pain; Cancer Pain; Chronic Back Pain; Postoperative Pain; Migraine; Fibromyalgia; Muscle sprain/strain; Bone fracture; Other Indications
  • 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
  • Companies Mentioned: Novartis AG; Eli Lilly And Company; Abbott Laboratories; Endo International plc; Purdue Pharma L.P.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

A pain management drug is a medication designed to reduce pain, achieving analgesia through actions at multiple levels of the nervous system. These actions include the inhibition of neurotransmitter release from the primary afferent terminals in the spinal cord and the activation of descending inhibitory controls in the midbrain.

The primary classes of pain management drugs comprise non-steroidal anti-inflammatory drugs (NSAIDs), anesthetics, anticonvulsants, anti-migraine agents, antidepressants, opioids, and nonnarcotic analgesics. NSAIDs, or nonsteroidal anti-inflammatory drugs, are specifically designed to lower a high fever, reduce inflammation, and alleviate discomfort. They find application in various conditions such as arthritic pain, neuropathic pain, cancer pain, chronic back pain, postoperative pain, migraine, fibromyalgia, muscle sprain/strain, bone fractures, among others. These drugs are distributed through different channels including hospital pharmacies, retail pharmacies, and online pharmacies.

The pain management drugs market research report is one of a series of new reports from The Business Research Company that provides pain management drugs market statistics, including pain management drugs industry global market size, regional shares, competitors with a pain management drugs market share, detailed pain management drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the pain management drugs industry. This pain management drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pain management drugs market size has grown strongly in recent years. It will grow from $76.76 billion in 2023 to $81.08 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The growth observed in the historical period can be attributed to factors such as the increase in chronic pain cases, a rise in cancer cases, heightened surgical procedures, improved methods of pain assessment, and government initiatives.

The pain management drugs market size is expected to see strong growth in the next few years. It will grow to $100.94 billion in 2028 at a compound annual growth rate (CAGR) of 5.6%. The anticipated growth in the forecast period can be attributed to the adoption of non-opioid alternatives, the development of targeted therapies, precision medicine approaches, implementation of psychological interventions, and a concentrated effort on minimizing side effects. Key trends expected in the forecast period encompass the adoption of value-based care models, expanded access programs, the exploration of combination therapies, the development of innovative formulations, and the emergence of biosimilar pain drugs.

The anticipated increase in the number of surgeries is poised to drive the growth of the pain management drugs market. Surgical procedures involve medical interventions that cut or penetrate the body's tissues for therapeutic purposes or to enhance bodily functions. Pain management drugs are crucial in surgeries as they help control and alleviate post-operative pain, contributing to improved patient comfort and recovery. In 2021, surgical procedures saw a substantial increase of 54% compared to 2020, with non-surgical procedures also rising by 44%, as reported by the Aesthetic Society. This surge in the rate of surgeries is a significant factor propelling the pain management drugs market.

The growth of the pain management drugs market is further expected to be boosted by the rise in the geriatric population. The geriatric population, comprising individuals aged 65 and older, often requires pain management drugs to alleviate conditions such as arthritis, cancer, and neurological disorders that are more prevalent in later life. According to a report by the World Health Organization (WHO) in October 2022, it is projected that by 2030, one in six individuals globally will be 60 years or older, and the number of individuals over 60 will double to 2.1 billion by 2050. Additionally, between 2020 and 2050, there will be an increase of 426 million people aged 80 or older. This demographic shift toward an aging population is a driving force behind the growth of the pain management drugs market.

A key trend gaining traction in the pain management drugs market is technological advancement. Major companies in this market are dedicated to developing innovative technologies to address pain management needs. For example, in November 2021, AppliedVR, Inc., a U.S.-based company offering virtual reality therapeutics, introduced EaseVRx, a prescription-only immersive virtual reality system designed to help patients with chronic lower back pain. Utilizing cognitive behavioral therapy and other behavioral techniques, EaseVRx employs 56 VR sessions over eight weeks to reduce pain and pain interference. This application of behavioral therapy principles through virtual reality represents a notable technological advancement in pain management.

Major companies in the pain management drugs market are developing drugs and obtaining FDA approval. FDA approval, indicating adherence to safety and efficacy standards, is crucial for commercial distribution in the United States. For instance, in October 2023, Hyloris Pharmaceuticals, a Belgium-based pharmaceutical company, received FDA approval for Maxigesic IV. This non-opioid intravenous painkiller, combining paracetamol and ibuprofen, offers a dual-action mechanism for pain relief and represents a significant advancement in the market, providing a new non-opioid treatment option for post-operative pain relief.

In November 2021, Pacira BioSciences, a U.S.-based pharmaceutical company, completed the acquisition of Flexion Therapeutics for $427.5 million. This strategic move strengthens Pacira's position in non-opioid pain management and expands its product portfolio to offer comprehensive non-opioid solutions along the pain pathway. The acquisition includes Flexion's ZILRETTA, an extended-release treatment for osteoarthritis knee pain, along with two clinical-stage pain medication candidates, FX201 and FX301. Flexion Therapeutics, a U.S.-based biopharmaceutical company, has a focus on non-opioid pain management.

Major companies operating in the pain management drugs market report are Novartis AG, Eli Lilly And Company, Abbott Laboratories, Endo International plc, Purdue Pharma L.P., Pfizer Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., GlaxoSmithKline plc, AbbVie Inc., Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Mylan N.V., Bausch Health Companies Inc., Becton Dickinson and Company, Boston Scientific Corporation, Baxter International Inc., Sanofi, Medtronic PLC, F. Hoffmann-La Roche Ltd., Boehringer Ingelheim, Mallinckrodt Pharmaceuticals, Allergan, Daiichi Sankyo Company Limited, Grunenthal GmbH, Mundipharma International Limited, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Zydus Cadila, Lupin Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd

North America was the largest region in the pain management drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the pain management drug market report during the forecast period. The regions covered in the pain management drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pain management drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pain management drug market consists of sales of acetaminophen, anti-seizure medications, steroids, muscle relaxers, and other related drugs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Pain Management Drugs Market Characteristics

3. Pain Management Drugs Market Trends And Strategies

4. Pain Management Drugs Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Pain Management Drugs Market Size and Growth

  • 5.1. Global Pain Management Drugs Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Pain Management Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Pain Management Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pain Management Drugs Market Segmentation

  • 6.1. Global Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • Anesthetics
  • Anticonvulsants
  • Anti-migraine Agents
  • Antidepressants
  • Opioids
  • Nonnarcotic Analgesics
  • 6.2. Global Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Arthritic Pain
  • Neuropathic Pain
  • Cancer Pain
  • Chronic Back Pain
  • Postoperative Pain
  • Migraine
  • Fibromyalgia
  • Muscle sprain/strain
  • Bone fracture
  • Other Indications
  • 6.3. Global Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

7. Pain Management Drugs Market Regional And Country Analysis

  • 7.1. Global Pain Management Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Pain Management Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pain Management Drugs Market

  • 8.1. Asia-Pacific Pain Management Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pain Management Drugs Market

  • 9.1. China Pain Management Drugs Market Overview
  • 9.2. China Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pain Management Drugs Market

  • 10.1. India Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pain Management Drugs Market

  • 11.1. Japan Pain Management Drugs Market Overview
  • 11.2. Japan Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pain Management Drugs Market

  • 12.1. Australia Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pain Management Drugs Market

  • 13.1. Indonesia Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pain Management Drugs Market

  • 14.1. South Korea Pain Management Drugs Market Overview
  • 14.2. South Korea Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pain Management Drugs Market

  • 15.1. Western Europe Pain Management Drugs Market Overview
  • 15.2. Western Europe Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pain Management Drugs Market

  • 16.1. UK Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pain Management Drugs Market

  • 17.1. Germany Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pain Management Drugs Market

  • 18.1. France Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pain Management Drugs Market

  • 19.1. Italy Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pain Management Drugs Market

  • 20.1. Spain Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pain Management Drugs Market

  • 21.1. Eastern Europe Pain Management Drugs Market Overview
  • 21.2. Eastern Europe Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pain Management Drugs Market

  • 22.1. Russia Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pain Management Drugs Market

  • 23.1. North America Pain Management Drugs Market Overview
  • 23.2. North America Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pain Management Drugs Market

  • 24.1. USA Pain Management Drugs Market Overview
  • 24.2. USA Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pain Management Drugs Market

  • 25.1. Canada Pain Management Drugs Market Overview
  • 25.2. Canada Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pain Management Drugs Market

  • 26.1. South America Pain Management Drugs Market Overview
  • 26.2. South America Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pain Management Drugs Market

  • 27.1. Brazil Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pain Management Drugs Market

  • 28.1. Middle East Pain Management Drugs Market Overview
  • 28.2. Middle East Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pain Management Drugs Market

  • 29.1. Africa Pain Management Drugs Market Overview
  • 29.2. Africa Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pain Management Drugs Market Competitive Landscape And Company Profiles

  • 30.1. Pain Management Drugs Market Competitive Landscape
  • 30.2. Pain Management Drugs Market Company Profiles
    • 30.2.1. Novartis AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Eli Lilly And Company
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Abbott Laboratories
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Endo International plc
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Purdue Pharma L.P.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Pain Management Drugs Market Competitive Benchmarking

32. Global Pain Management Drugs Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Pain Management Drugs Market

34. Pain Management Drugs Market Future Outlook and Potential Analysis

  • 34.1 Pain Management Drugs Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Pain Management Drugs Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Pain Management Drugs Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer